WHO ICTRP trial
Effect of proactive and retroactive medication reconciliation in the admission…
IRCT20120215009014N494 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20120215009014N494 |
|---|---|
| Public title | Effect of proactive and retroactive medication reconciliation in the admission time on the reduction of medication error in patients with acute coronary syndrome |
| Scientific title | Effect of proactive and retroactive medication reconciliation in the admission time on the reduction of medication error in patients with acute coronary syndrome: a randomized clinical trial study |
| Primary sponsor | Hamedan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Acute coronary syndrome. Acute coronary thrombosis not resulting in myocardial infarction;I24.0 |
| Interventions | Intervention 1: Intervention group: In the proactive group, after the patient is hospitalized and before the physician prescribes medication, the researcher prepares a complete history of the patient s medications by referring to the… |
| Registration date | Jan 2, 2024 |
| Target size | 162 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: